Globus Medical’s first quarter delivered results ahead of Wall Street’s expectations, but the market reacted negatively, with ...
As you might know, Globus Medical, Inc. ( NYSE:GMED ) just kicked off its latest first-quarter results with some ...
GMED is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of GMED shares has increased $0.94 since the market last closed. This is a 1.23% ...
Centerpoint Health – Georgetown continues to expand its advanced surgical capabilities with the acquisition of ExcelsiusGPS ...
Shares of Globus Medical fell after the musculoskeletal medical device company reaffirmed its guidance for full-year revenue. The stock declined 8.3%, to $78.03, Friday afternoon and is down 11% year ...
Globus Medical (NYSE:GMED) reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the ...
Q1 2026 earnings call recap: revenue $759.9M, EPS $1.12, raised FY EPS to $4.70-$4.80; robotics lease mix & Nevro risks—read now.
The Globus family of brands has launched a new portal and education platform for travel advisors, along with a B2B ad campaign that highlights the importance of advisors to Globus' business. The ...